Tag Archives: J&J COVID-19 SHOT GETS BETTER BOOST FROM MODERNA OR PFIZER IN STUDY

People who got Johnson & Johnson’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer/BioNTech or Moderna, a study run by the National Institutes of Health showed on Wednesday. The study, which is preliminary and hasn’t been peer reviewed, is the latest challenge to J&J’s efforts to use its COVID-19 vaccine as …

Read More »